As the PrEP category expands to include new products, our marketing and demand generation efforts must communicate with young women about PrEP and product choice in their language so they are ultimately inspired to act. That’s why MOSAIC set out to build a strong, evidence-informed, unified brand for the category.
Continue ReadingCategory: Product Introduction
JUMP-STARTING PrEP INTRODUCTION: LEVERAGING MOSAIC’S TEMPLATE GUIDELINES TO CREATE AN ENABLING POLICY ENVIRONMENT
When a country is poised to introduce a new biomedical prevention product, policymakers want to ensure that their rollout plan is based on the latest science and provides clear, standardized procedures for implementation. The WHO publishes global guidance on delivering new HIV prevention products, but those recommendations need to be adapted to the local context.
Continue ReadingNEW DATA, NEW OPPORTUNITIES: THE EXPANDING EVIDENCE BASE FOR THE PrEP RING
Three MTN studies – REACH, DELIVER, and B-PROTECTED – recently published critical new data on PrEP ring use among adolescent girls and young women (AGYW), pregnant individuals, and breastfeeding individuals in Africa. All studies offer compelling evidence that the ring is safe for use among these populations.
Continue ReadingCATALYZING THE NEXT GENERATION OF HIV PREVENTION: FROM IMPLEMENTATION SCIENCE TO PROGRAM INTEGRATION
Through oral PrEP, condoms, voluntary medical male circumcision, and antiretroviral treatment, USAID has helped to expand prevention options and access for all. Today, USAID continues to provide global leadership in the HIV response by expanding access to options with a new generation of HIV prevention products.
Continue ReadingIAS 2023 SATELLITE SESSION | PREPARING FOR THE INTRODUCTION OF INJECTABLE CABOTEGRAVIR FOR HIV PREVENTION IN ASIA
This IAS 2023 session will review evidence from recent studies designed to inform CAB PrEP introduction in Asia; identify regional priorities for a CAB implementation science agenda; examine regional lessons from oral PrEP introduction and scale-up; highlight progress and lessons from preparing for CAB rollout in Africa; and introduce available policy and program planning tools and resources to help countries prepare for CAB rollout.
Continue ReadingWE NEED TO APPLY A GENDER-TRANSFORMATIVE LENS TO PrEP MARKETING
As marketing for PrEP has evolved, we have seen a shift away from strategies we know don’t work: fear-based, stigma-reinforcing, HIV-centric, medicalized, and far-future focused. Yet we need to go a step further and analyze all the insights that form the backbone of our campaigns and our messages through a gender-transformative lens.
Continue ReadingTHE CATALYST STUDY: CATALYZING ACCESS TO NEW PREVENTION PRODUCTS TO STOP HIV
We are excited to announce the launch of Catalyzing Access to New Prevention Products to Stop HIV (CATALYST), MOSAIC’s flagship product introduction study. CATALYST will provide and assess an enhanced service delivery package that includes oral PrEP, the PrEP ring, and injectable cabotegravir for PrEP.
Continue ReadingPOSITIONING PrEP FOR SUCCESS: SIX KEY LESSONS
Demand for oral PrEP has been an issue. How can we do marketing differently with a multi-product PrEP portfolio? What do we want young women’s hearts to feel—and minds to think—about PrEP? These question about the positioning of PrEP are central to its branding as a multi-product category.
Continue ReadingTHE FUTURE OF PrEP: IMPLEMENTATION STUDIES TO GUIDE THE ROLLOUT OF NEW PrEP PRODUCTS
As new PrEP products move out of clinical trials and toward market entry, implementation research has a pivotal role to play in guiding the introduction and scale-up of these new products in real-world service delivery settings.
Continue ReadingCHAMPIONING CHOICE IN A MULTI-PRODUCT HIV PREVENTION MARKET
New products, including the dapivirine vaginal ring and injectable cabotegravir, have been approved in several countries, and more biomedical prevention products are in development. As the catalog of HIV prevention products expands, so too does the conversation about the importance of upholding choice to optimize the benefits for potential PrEP users.
Continue Reading